Rystiggo (rozanolixizumab-noli) - UCB
Rituxan (rituximab) - Roche
Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) - argenx
Soliris (eculizumab) - AstraZeneca
Ultomiris (ravulizumab-cwvz) - AstraZeneca
Zilbrysq (zilucoplan) - UCB
http://www.ncbi.nlm.nih.gov/pubmed/42717567
 
Adela Della Marina; Andreas Meisel; Benedikt Schoser; Charlotte Schubert; Christiane Schneider-Gold; Christoph Kleinschnitz; Fritz Zimprich; Heidrun H Krämer; Jan D Lünemann; Jana Zschüntzsch; Jörn Peter Sieb; Michael Schroeter; Paolo Doksani; Sarah Hoffmann; Sven G Meuth; Tim Hagenacker; Tobias Ruck; Ulrike Schara-Schmidt
 
Sep 11, 2026
 
Prev Next